Myelin and traumatic brain injury: The copper deficiency hypothesis

Medical Hypotheses

Volumn 81, Issue 6, 2013, Pages 995-998

  Klevay, Leslie M ^a  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER; MYELIN; MYELIN BASIC PROTEIN;

ARTICLE; BIOCHEMISTRY; CLINICAL ASSESSMENT; COPPER DEFICIENCY; COPPER METABOLISM; DEMYELINATION; DIETARY INTAKE; HUMAN; HYPOTHESIS; NEUROPATHY; NONHUMAN; TRAUMATIC BRAIN INJURY;

ANIMALIA;

BIOSYNTHETIC PATHWAYS; BRAIN INJURIES; COPPER; HUMANS; MODELS, BIOLOGICAL; MYELIN BASIC PROTEIN; MYELIN SHEATH;

EID: 84888431585     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2013.09.011     Document Type: Article

References (63)

1. Klevay L.M. Four ways of becoming ill. Med Hypotheses 1988, 27:65-70.
2. Anon, Injury prevention & control: Traumatic brain injury 36 (2013) 366-378. http://www.cdc.gov/TraumaticBrainInjury/statistics.html.
3. Su E., Bell M.J., Kochanek P.M., et al. Increased CSF concentrations of myelin basic protein after TBI in infants and children: absence of significant effect of therapeutic hypothermia. Neurocrit Care 2012, 17:401-407.
4. Raymond G.V., Seidman R., Monteith T.S., et al. Head trauma can initiate the onset of adreno-leukodystrophy. J Neurol Sci 2010, 290:70-74.
5. Hart J., Kraut M.A., Womack K.B., et al. Neuroimaging of cognitive dysfunction and depression in aging retired national football league players: a cross-sectional study. JAMA Neurol 2013, 70:326-335.
6. Tremblay S., De Beaumont L., Henry L.C., et al. Sports concussions and aging: a neuroimaging investigation. Cereb Cortex 2013, 23:1159-1166. (New York, N.Y.: 1991).
7. Dash P.K., Redell J.B., Hergenroeder G., Zhao J., Clifton G.L., Moore A. Serum ceruloplasmin and copper are early biomarkers for traumatic brain injury-associated elevated intracranial pressure. J Neurosci Res 2010, 88:1719-1726.
8. Flygt J., Djupsjo A., Lenne F., Marklund N. Myelin loss and oligodendrocyte pathology in white matter tracts following traumatic brain injury in the rat. Eur J Neurosci 2013, 38:2153-2165.
9. Akbik F., Cafferty W.B., Strittmatter S.M. Myelin associated inhibitors: a link between injury-induced and experience-dependent plasticity. Exp Neurol 2012, 235:43-52.
10. Creed J.A., DiLeonardi A.M., Fox D.P., Tessler A.R., Raghupathi R. Concussive brain trauma in the mouse results in acute cognitive deficits and sustained impairment of axonal function. J Neurotrauma 2011, 28:547-563.
11. Klevay L.M. Is the Western diet adequate in copper?. J Trace Elem Med Biol 2011, 25:204-212.
12. Klevay L.M. Copper deficiency in Canadian octogenarians?. Rejuvenation Res 2008, 11:697-698.
13. Klevay L.M. Intakes of copper in nutrition surveys are falsely high. Am J Clin Nutr 2012, 95:1293-1294.
14. Collins J.F., Klevay L.M. Copper. Adv Nutr 2011, 2:520-522.
15. Ropper A.H., Samuels M.A. Adams and Victor's principles of neurology 2009, McGraw-Hill Medical, New York, p. 1120-1215. 9th ed.
16. Zara G., Grassivaro F., Brocadello F., Manara R., Pesenti F.F. Case of sensory ataxic ganglionopathy-myelopathy in copper deficiency. J Neurol Sci 2009, 277:184-186.
17. Khaleeli Z., Healy D.G., Briddon A., et al. Copper deficiency as a treatable cause of poor balance. BMJ 2010, 340:864-866.
18. Liu P.C., Chen Y.W., Centeno J.A., Quezado M., Lem K., Kaler S.G. Downregulation of myelination, energy, and translational genes in Menkes disease brain. Mol Genet Metab 2005, 85:291-300.
19. Kumar N. Copper deficiency myelopathy (human swayback). Mayo Clin Proc 2006, 81:1371-1384.
20. Kelkar P., Chang S., Muley S.A. Response to oral supplementation in copper deficiency myeloneuropathy. J Clin Neuromuscul Dis 2008, 10:1-3.
21. Jaiser S.R., Winston G.P. Copper deficiency myelopathy. J Neurol 2010, 257:869-881.
22. Prodan C.I., Rabadi M., Vincent A.S., Cowan L.D. Copper supplementation improves functional activities of daily living in adults with copper deficiency. J Clin Neuromuscul Dis 2011, 12:122-128.
23. Owen C.A. Biochemical aspects of copper 1982, Noyes Publications, Park Ridge, N.J., p. 1-205. 1st ed.
24. Davis G.K., Mertz W. Copper (5 ed.). Trace elements in human and animal nutrition 1987, vol. 1:301-364. Academic Press, San Diego.
25. Prohaska J.R. Biochemical changes in copper deficiency. J Nutr Biochem 1990, 1:452-461.
26. Linder M.C., Goode C.A. Biochemistry of copper 1991, Plenum Press, New York.
27. Carrico R.J., Deutsch H.F. Isolation of human hepatocuprein and cerebrocuprein. Their identity with erythrocuprein, J Biol Chem 1969, 244:6087-6093.
28. Gerzer R., Böhme E., Hofmann F., Schultz G. Soluble guanylate cyclase purified from bovine lung contains heme and copper. FEBS Lett 1981, 132:71-74.
29. Davies K.M., Hare D.J., Cottam V., et al. Localization of copper and copper transporters in the human brain. Metall Integr Biometal Sci 2013, 5:43-51.
30. Everson G.J., Tsai H.C., Wang T.I. Copper deficiency in the guinea pig. J Nutr 1967, 93:533-540.
31. Berg J.M., Tymoczko J.L., Stryer L. Biochemistry 2007, Freeman, New York. 6th ed.
32. Voet D., Voet J.G. Biochemistry 2011, John Wiley, Hoboken NJ.
33. Devlin T.M. Textbook of biochemistry, with clinical correlations 2011, John Wiley, Hoboken NJ.
34. Schlief M.L., Gitlin J.D. Copper homeostasis in the CNS: a novel link between the NMDA receptor and copper homeostasis in the hippocampus. Mol Neurobiol 2006, 33:81-90.
35. Lutsenko S. Human copper homeostasis: a network of interconnected pathways. Curr Opin Chem Biol 2010, 14:211-217.
36. Gertz S.D., Tadmor R. Liebman's neuroanatomy made easy and understandable 2007, Austin, Texas. pro ed.
37. Nolte J. Sundsten 2009, J, The human brain, Mosby/Elsevier, Philadelphia.
38. Hauser S.L., Beal M.F. Biology of neurologic diseases (Harrison's Online ed.). Harrison's Principles of internal medison, 18e 2013, McGraw-Hill, (Chapter 366). D.L. Longo, A.S. Fauci, D.L. Kasper, S.L. Hauser, J.L. Jameson, J. Loscalzo (Eds.).
39. Voet D., Voet J.G Biochemistry 2004, John Wiley, Hoboken, NJ.
40. Emery B. Regulation of oligodendrocyte differentiation and myelination. Sci 2010, 330:779-782.
41. Ruckh J.M., Zhao J.W., Shadrach J.L., et al. Rejuvenation of regeneration in the aging central nervous system. Cell Stem Cell 2012, 10:96-103.
42. Follis R.H. The pathology of nutritional diseases 1948, Thomas, C.C., Springfield.
43. Pletcher J.M., Banting L.F. Copper deficiency in piglets characterized by spongy myelopathy and degenerative lesions in the great blood vessels. J S Afr Vet Assoc 1983, 54:43-46.
44. Narayan S.K., Kaveer N. CNS demyelination due to hypocupremia in Wilson's disease from overzealous treatment. Neurol India 2006, 54:110-111.
45. Benetti F., Ventura M., Salmini B., et al. Cuprizone neurotoxicity, copper deficiency and neurodegeneration. Neurotoxicol 2010, 31:509-517.
46. Matsushima G.K., Morell P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 2001, 11:107-116.
47. Torkildsen O., Brunborg L.A., Myhr K.M., Bo L. The cuprizone model for demyelination. Acta Neurol Scand Suppl 2008, 188:72-76.
48. Doucette J.R., Jiao R., Nazarali A.J. Age-related and cuprizone-induced changes in myelin and transcription factor gene expression and in oligodendrocyte cell densities in the rostral corpus callosum of mice. Cell Mol Neurobiol 2010, 30:607-629.
49. Anon. Copper At a Glance http://labtestsonline.org/understanding/analytes/copper/tab/glance. 2012.
50. Owen C.A. Physiological aspects of copper 1982, Noyes Publications, Park Ridge, N.J.
51. Klevay L.M., Inman L., Johnson L.K., et al. Increased cholesterol in plasma in a young man during experimental copper depletion. Metabolism 1984, 33:1112-1118.
52. Milne D.B., Klevay L.M., Hunt J.R. Effects of ascorbic acid supplements and a diet marginal in copper on indices of copper nutriture in women. Nutr Res 1988, 8:865-873.
53. Klevay L.M., Saari J.T. Comparative responses of rats to different copper intakes and modes of supplementation. Proc Soc Exp Biol Med 1993, 203:214-220.
54. Klevay L.M. Iron overload can induce mild copper deficiency. J Trace Elem Med Biol 2001, 14:237-240.
55. Klevay L.M., Canfield W.K., Gallagher S.K., et al. Decreased glucose tolerance in two men during experimental copper depletion. Nutr Rep Intern 1986, 33:371-382.
56. Pepys M.B. The acute phase response and C-reactive protein (2 ed.). Oxford Textbook of Medicine 1996, 1527-1533. Oxford University Press, Oxford. D.J. Weatherall, J.G. Ledingham, D.A. Warrell (Eds.).
57. Klevay LM. Copper (2 ed.). In: Coates PM, Betz JM, Blackman MR, Cragg GM, Levine M, Moss J, White JD, editors. Encyclopedia of Dietary Supplements. London: Informa Healthcare; 2010. p. 175-84.
58. Koh E.T., Reiser S., Fields M., Scholfield D.J. Copper status in the rat is affected by modes of copper delivery. J Nutr 1989, 119:453-457.
59. Tamura T., Hong K.H., Mizuno Y., Johnston K.E., Keen C.L. Folate and homocysteine metabolism in copper-deficient rats. Biochim Biophys Acta 1999, 1427:351-356.
60. Prohaska J.R., Brokate B. Lower copper, zinc-superoxide dismutase protein but not mRNA in organs of copper-deficient rats. Arch Biochem Biophys 2001, 393:170-176.
61. Dietary reference intakes: applications in dietary planning 2003, Anon, National Academy of Sciences, Washington, D.C., p. 2.
62. Tamura T., Turnlund J.R. Effect of long-term, high-copper intake on the concentrations of plasma homocysteine and B vitamins in young men. Nutrition 2004, 20:757-759.
63. Pratt W.B., Omdahl J.L., Sorenson J.R. Lack of effects of copper gluconate supplementation. Am J Clin Nutr 1985, 42:681-682.